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Traditional medicine caters for about 80% of the health care needs of many rural populations around the
world, especially in developing countries. In addition, plant-derived compounds have played key roles in drug
discovery. Malaria is currently a public health concern in many countries in the world due to factors such as
chemotherapy faced by resistance, poor hygienic conditions, poorly managed vector control programmes and
no approved vaccines. In this review, an attempt has been made to assess the value of African medicinal
plants for drug discovery by discussing the anti-malarial virtue of the derived phytochemicals that have been
tested by in vitro and in vivo assays. This survey was focused on pure compounds derived from African flora
which have exhibited anti-malarial properties with activities ranging from “very active” to “weakly active”.
However, only the compounds which showed anti-malarial activities from “very active” to “moderately active”
are discussed in this review. The activity of 278 compounds, mainly alkaloids, terpenoids, flavonoids, coumarines,
phenolics, polyacetylenes, xanthones, quinones, steroids, and lignans have been discussed. The first part of this
review series covers the activity of 171 compounds belonging to the alkaloid and terpenoid classes. Data
available in the literature indicated that African flora hold an enormous potential for the development of
phytomedicines for malaria.
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Malaria is an infectious disease with ravaging effects in
the world. The World Health Organization (WHO) has
published statistics which reveal that half the world’s
population is at risk of malaria and that one to two mil-
lion annual deaths can be attributed to malaria alone
[1,2]. Four protozoan species of the genus Plasmodium
(Plasmodium falciparum, Plasmodium malariae, Plas-
modium ovale, and Plasmodium vivax) are responsible
for this infection, although the majority of fatal cases are
caused by P. falciparum [3]. Malaria has been treated* Correspondence: lmbazze@yahoo.fr
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article, unless otherwise stated.with quinine, chloroquine, mefloquine, and artemisinin
(Figure 1), among other drugs. However, the protozoans
have developed resistance against many of the current
treatment regimens [4]. In the quest to identify new
anti-malarial chemotherapeutic agents, many research
groups have resorted to plant sources [3,5,6]. This is be-
cause of the use of many of these plant materials in the
treatment of malaria and fevers in African traditional
medicine (ATM) [7]. There has been a general call for
the use of natural products as drugs for malaria or as
sources of inspiration for the development of novel anti-
malarials [8-11] in order to possibly avoid problems re-
lated to drug resistance [12].
The African continent is very rich in floral biodiversity
and its plant materials are endowed with natural products
(NPs) with intriguing chemical structures and promisingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public






















Figure 1 Some plant-derived anti-malarial drugs.
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malarials or the scaffolds necessary for their synthesis may
be found in plants currently used in ATM [13,14]. It
should also be mentioned that malaria mostly affects
the populations of Africa, Asia and Latin Africa. Asia
has offered artemisinin to humanity while Latin Amer-
ica has offered quinine. Many researchers are therefore
of the opinion that it is Africa’s turn to offer a new anti-
malarial drug to humanity. Why do we not yet find a
(real) anti-malarial drug from Africa? This brings us to
the need to have an overview of the anti-malarial/anti-
plasmodial activity of compounds from bitter African
plants (alkaloids and terpenoids). Several research
groups in Africa have been involved in the bioassay-
guided fractionation of plant extracts, leading to the iso-
lation, purification and characterization of a significant
number of NPs, some with remarkable anti-malarial ac-
tivities. The literature survey reported in this work has
led to the identification of several vast screening efforts
of crude extracts derived from plants used in ATM, har-
vested from the following countries, just to mention a
few: the Democratic Republic of Congo [15,16], Nigeria
[17-19], Mozambique, Cape Verde, Guinea-Bissau, São
Tomé and Príncipe and Angola [20], Mali and São Tomé
and Príncipe [21], Madagascar [22-24], Congo [25], Benin
[26], Burkina Faso [27], South Africa [28], Ivory Coast [29],
West African countries [30], Tanzania [31], Kenya [32], and
East African countries [33,34].
The potential of plant-derived NPs for anti-malarial
drug discovery has been examined in a number of re-
view papers [3,35-41]. Other review articles have con-
centrated on anti-malarials from specific countries/
regions in Africa [19,20,42-46]. However, there has been
no review offering coverage of promising anti-malarials
from the entire African continent in the last ten years
[13]. In this review series, the potential of plant-derived
NPs that could be developed into drugs have been dis-
cussed, by giving an overview of the most pertinent
in vitro and in vivo screening results reported in the
literature.Promising anti-malarial alkaloids and terpenoids derived
from African flora
Alkaloids
Previous studies have shown that plant-derived alkaloids
have a great potential for anti-malarial drug develop-
ment [33-36,39,40,42-44]. Tables 1 and 2 summarize the
most promising alkaloids derived from African medicinal
plants with significant anti-malarial properties. The chem-
ical structures are shown in Figures 2, 3, 4, 5, 6 and 7, ac-
cording to the alkaloid subclasses.
Indole alkaloids
Several indole alkaloids, derived from African medicinal
plants, have shown interesting in vitro anti-malarial ac-
tivities, among them compounds 1, 2 and 10 to 19. Nkunya
et al. have isolated prenylated indole alkaloids from
Monodora and Isolona species (Annonaceae) growing in
Tanzania [47]. According to their report, 6-(3-methyl-but-
2-enyl)-1,3-dihydro-indol-2-one (1), 3-[6-(3-methyl-but-
2-enyl)-1H-indolyl]-6-(3- methyl-but-2-enyl)-1H-indole or
annonidine F (2), 1H-indole-5-carbaldehyde (3), 6-(3-me-
thyl-2-butenyl)-1H-indole (4), 6-(3-methylbuta-1,3-dienyl)-
1H-indole (5), 6-(4-oxo-but-2-enyl)-1H-indole (6) and
3-geranylindole (7) were isolated fromMonodora angolensis
while 3-(1,1-dimethyl-but-2-enyl)-5-(3-methyl-but-2-enyl)-
1H-indole or caulidine A (8), 4-[3-(1,1-dimethyl-but-2-
enyl)-1H-indol-5-yl]-but-3-en-2-one or caulidine B (9),
5-(3-methyl-2-butenyl)-1H-indole and 5-(3-methylbuta-1,
3-dienyl)-1H-indole were obtained from Isolona cauliflora.
The compounds with the most promising, measured, anti-
malarial activities were 1 and 2, both having in vitro anti-
malarial activities against the multidrug resistant strain K1
of P. falciparum (IC50 = 21 μg mL
-1 for each compound).
Moreover, their measured cytotoxicities, in the brine
shrimp test were IC50 = 4.08 and 5.28 μg mL
-1, respectively.
The compound 17-O-acetyl,10-hydroxycorynantheol (10)
was isolated from Strychnos usambarensis (harvested in
Rwanda), along with isostrychnopentamine (18), the main
alkaloid responsible for the anti-plasmodial activity of the
plant, by Cao et al. [48]. The study showed that









Indole alkaloids 1, 2, 3, 4,
5, 6 and 7
Monodora angolensis (Annonaceae) Stem and
root bark
Kiwanda, Tanzania Nkunya et al. [47]




Nkunya et al. [47]
10 Strychnos usambarensis (Loganiaceae) Leaves Akagera National Park,
Rwanda
Cao et al. [48]
11 and 12 Penianthus longifolius (Menispermaceae) Stem bark Cameroon Bidla et al. [49]
13 Glossocalyx brevipes (Siparunaceae) Leaves Kumba, Cameroon Mbah et al. [50]
14 Fagara zanthoxyloides (Rutaceae) Roots Nigeria Odebiyi et al. [51]
15 Picralima nitida (Apocynaceae) Fruits Nnewi, Nigeria Okunji et al. [52]
16 Strychnos usambarensis (Loganiaceae) Roots Akagera National Park,
Rwanda
Frédérich et al. [55]
17, 18
and 19
Strychnos usambarensis (Loganiaceae) Leaves Akagera National Park,
Rwanda
Frédérich et al. [56]
Naphthoisoquinolines 20, 21, 22,
23 and 24




Bringmann et al. [57]
25, 26, 27,
28 and 29
Ancistrocladus tanzaniensis (Acistrocladaceae) Leaves Uzungwa Mountains,
Tanzania
Bringmann et al. [58]
30 Triphyophyllum peltatum (Dioncophyllaceae) Roots Parc de Taï,
West Ivory Coast
Bringmann et al. [59]
31 Triphyophyllum peltatum (Dioncophyllaceae) Root bark West Ivory Coast Bringmann et al. [60]
32 Mixture of Triphyophyllum peltatum,a
Dioncophyllum tholloniib and Habropetalum
daweic (Dioncophyllaceae)











West Ivory Coastb François et al. [66]b
Furoquinolines 37 and 38 Vepris uguenensis (Rutaceae) Roots Baringo District, Kenya Cheplogoi et al. [68]
39 and 40 Toddalia asiatica (Rutaceae) Roots Ol Ari Nyiro Ranch,
Kenya
Gakunju et al. [69]
41 Teclea gerrardii (Rutaceae) Root bark Durban, South Africa Waffo et al. [70]
a,b and ccorrespond to the respective references.
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indole alkaloids known to date, showing an in vitro activ-
ity against P. falciparum close to 5 μM and a high
selectivity.
Indoles with interesting anti-malarial properties have
also been derived from two plant species growing in
Cameroon: Penianthus longifolius and Glossocalyx bre-
vipes [49,50]. Bilda et al. have isolated palmitine (11)
and jatrorrhizine (12) from the stem bark of Penianthus
longifolius. Compounds 11 and 12 showed promising
in vitro activities on various strains of P. falciparum with
IC50 values ranging from 0.28 to 0.35 μg mL
-1 [49],
meanwhile Mbah et al. isolated liriodenine (13) from
Glossocalyx brevipes (Siparunaceae), which exhibited
anti-malarial activity against the D-6 drug sensitivestrain from Sierra Leone and the NF54 strain with IC50
values of 2.37 μM and 1.32 μM, respectively [50].
From the plant species growing in Nigeria, fagaronine
(14) and alstonine (15) were derived from Fagara
zanthoxyloides (Rutaceae) and Picralima nitida (Apocyna-
ceae) respectively [51,52]. While fagaronine (14) inhibited
P. falciparum growth in vitro at IC50 = 0.018 μg mL
-1,
alstonine (15) has been noted to be the most active indole
alkaloid derived from Picralima nitida [53]. It is note-
worthy that indole and dihydroindole alkaloids are
common in Picralima nitida growing in Nigeria, the
major constituents including akuammiline, akuammidine,
akuammine, akuammigine, akuammicine, picraline, and
alstonine [54]. Some of the aforementioned alkaloids have
exhibited in vitro anti-malarial activity against P. falciparum
Table 2 Summary of anti-malarial alkaloids derived from the African flora – acridones, amides and cryptolepines
Compound
subclass





Acridones 42a, b, cand 43 b Teclea gerrardiia Root barka Durban, South Africaa Waffo et al. [70]a
Zanthoxylum leprieuriib Fruitsb Yaoundé, Cameroonb Tchinda et al. [71]b
Teclea trichocarpac Leavesc
(Rutaceae)
44, 45, 46, 47, 48
and 49
Teclea trichocarpa (Rutaceae) Leaves Nairobi, Kenya Wurithi et al. [72]
50 Vepris uguenensis (Rutaceae) Roots Baringo District, Kenya Cheplogoi et al. [68],
Kiplimo [73]
Amides 51 Hugonia castaneifolia (Linaceae) Root bark Pugu forest, Tanzania Baraza et al. [74]
52 Beilschmiedia zenkeri (Lauraceae) Bark Yaoundé, Cameroon Lenta et al. [75]
Cryptolepines 53 Sida acuta (Malvaceae) Aerial parts Ivory Coast Banzounzi et al. [76]
53, 54, 55, 56, 57,
58, 59, 60, 61, 62,
63, and 63′
Cryptolepis sanguinolenta (Periplocaceae) Stemsa Mampong-Akwapim,
Ghana, Guinea Bissau
and other regions
Barku et al. [77]a
Root barkb Cimanga et al. [78,79]a, b
Rootsc Ablordeppey et al. [80]a
Paulo et al. [81]c
Hadden et al. [82]
a,b and ccorrespond to the respective references.
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values varying from 0.01 to 0.9 μg mL-1 [53].
Frédérich et al. examined the roots and leaves of Strych-
nos usambarensis (Loganiaceae) growing in Rwanda
[55,56]. Four potent anti-malarial bisindole alkaloids; 10′-
hydroxyusambarensine (16), strychnopentamine (17), iso-
strychnopentamine (18) and chrysopentamine (19) have
been isolated. Compounds 17 to 19 showed interesting
anti-malarial activities against chloroquine-sensitive line
(FCA 20) from Ghana (IC50 values from 117 to 579 nM),
against moderately chloroquine-resistant line (FCB1-R)
from Colombia (IC50 values from 107 to 550 nM) and
against chloroquine-resistant line (W2) from Indochina
(Laos) (IC50 values from 145 to 507 nM). The results of
anti-plasmodial activities were comparable to those of the
anti-malarial drugs quinine and chloroquine, which is in-
dicative of the absence of cross-resistance with chloro-
quine. Meanwhile, compound 16 had moderate in vitro
activity against two strains of P. falciparum.
Naphthoisoquinolines
These compounds are characterized by the C5/C8’ linkage
between the naphthalene and the isoquinoline portions of
these alkaloids (Figure 3). They have been isolated from
Ancistrocladus (Acistrocladaceae), Triphyophyllum, Dion-
cophyllum, and Habropetalum (Dioncophyllaceae) species.
The chemical significance of naphthylisoquinoline alka-
loids rests on their unique structure and their biological
activities [45,46].The anti-malarial properties of some of these species
have been investigated by Bringmann et al. [57-66]. Re-
garding the Acistrocladaceae-derived naphthoisoquino-
lines, compounds 20 to 24, derived from the stems and
leaves of Ancistrocladus robertsoniorum growing in Kenya,
exhibited moderate anti-malarial activities (IC50 values
from 2.0 to 15.9 μM) against the K-1 and NF54 strains of
P. falciparum [57], meanwhile the Tanzanian species,
Ancistrocladus tanzaniensis, gave compounds 25 to 29
with IC50 values ranging from 0.1 to 3.6 μg mL
-1 against
the K1 strain and between 1.9 and 34.1 μg mL-1 against
the 3D7 strain [58]. Habropetaline A (30) and 5′-O-
demethyl-dioncohylline A (31) were derived from the
roots of Triphyophyllum peltatum, harvested in the Parc
de Taï, in west Ivory Coast [59,60]. Both naphthoiso-
quinolines exhibited interesting anti-plasmodial activities
against drug-sensitive and drug-resistant strains of the
parasite. Habropetaline A (30) showed very good effect
against P. falciparum, without cytotoxicity, with respective
IC50 values of 5.0 and 2.3 ng mL
-1 for the strains K1
(chloroquine and pyrimethamine resistant) and NF54
(sensitive to all known drugs). Compound 30 was almost
as active as artemisinin (K1: 1.2 ng mL-1, NF54:
1.2 ng mL-1) and is known to be one of the most potent
NPs used against P. falciparum [59]. On the other hand,
5′-O-demethyl-dioncophylline A (31) showed improved
in vitro anti-malarial activity (IC50 = 0.340 μg mL
-1)
against the erythrocytic forms of P. falciparum [60]. Jozi-
























































Palmatine (11): R = Me





































Figure 2 Anti-malarial indole alkaloids derived from the African flora.








































































































Figure 3 Naphthoisoquinolines with anti-plasmodial activity, derived from plants used in African traditional medicine.






















































































Figure 5 Promising anti-malarial acridones from African medicinal
plants.
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http://www.malariajournal.com/content/12/1/449naphthylisoquinoline alkaloid dioncopeltine A (36), was
derived from a mixture of root and bark of Triphyophyllum
peltatum and Dioncophyllum thollonii, along with twigs of
Habropetalum dawei (Dioncophyllaceae), harvested from
different regions on the continent [61]. Although this
compound showed some in vitro anti-plasmodial activ-
ity against P. falciparum (K1 = 875 ng mL-1, NF54 =
2530 ng mL-1), it is significantly less active than its
monomeric precursor, dioncopeltine A (36) (K1 =
4.8 ng mL-1, NF54 = 3.3 ng mL-1). This observation
could lead to the conclusion that only naphthoisoquino-
lines containing one phenolic OH group each (such as
dioncophylline A (36) and ancistrocladine (28)), could
easily undergo the required dimerization reaction, im-
plying that doubling of the number of free OH groups
would increase the anti-plasmodial activity [61]. Dion-
cophyllines A (33), B (34) and C (35) and dioncopeltine
A (36) were also active in the in vivo rodent model [66],
with dioncophylline C (35) exhibiting a 50% effective
dosage (ED50) of 10.71 mg kg
-1 day-1. Four daily treat-
ments with 50 mg kg-1 day-1 were needed to achieve
radical cure, one oral dose being sufficient to kill 99.6%
of the parasites. Intravenous application of dioncophyl-
line C was shown to be even more effective, with an
ED50 of 1.90 mg kg
-1 day-1 and no noticeable toxic ef-
fects. Compound 35 also suppressed more established
Plasmodium berghei infections when orally applied at
day 3 after infection. It should be mentioned that rodent
malaria is a well-known animal model for testing newcompounds and plant extracts. However, trial in human
being is decisive to identify a “hit” as “a real hit”; and
this is a good way to assess toxicity and safety. Both
dioncopeltine A (36) and dioncophylline C (35) were
active against the chloroquine-resistant P. berghei Anka
CRS parasites. The naphthoisoquinolines are also known
to exhibit other biological activities, e.g. dioncophylline A
(33), is the main cytotoxin in Ancistrocladus letestui [67].
The above observations all point to the fact that naphthy-
lisoquinoline alkaloids are promising lead compounds for




















































Cryptolepinoic acid (62): R = COOH
Methyl cryptolepinoate (63): R = COOCH3




Figure 7 Anti-malarial cryptolepines from African medicinal
plants.
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This subclass of alkaloids is easily identified with the
Vepris,Toddalia and Teclea genera of the Rutaceae family.
From the roots of Vepris uguenensis, Cheplogoi et al. iso-
lated flindersiamine (37) and maculosidine (38) [68]. Al-
though compound 37 lacked anti-malarial efficacy against
all tested strains, maculosidine (38) exhibited moderate
anti-malarial activity against two strains of P. falciparum,
with IC50 values of 29.2 and 40.4 μg mL
-1 against
the chloroquine-susceptible 3D7 and the chloroquine-
resistant FCM29 strains respectively. Nitidine (39) has
been derived from the roots of Toddalia asiatica har-
vested in Kenya and modified to yield the reduced deriva-
tive 5,6-dihydronitidine (40) [69]. Even though nitidine is
mostly known for its potential anticancer properties, the
investigations of Gakunju et al. showed the alkaloidal ex-
tract of the roots of this plant to have high activity against
the chloroquine-resistant K39 strain of P. falciparum, with
an IC50 value of 0.04 μg mL
-1. Further phytochemical ana-
lysis on the extract by these authors yielded nitidine as a
major compound. In vitro screening against the K39 strain
of P. falciparum revealed that nitidine exhibited high anti-
plasmodial activity, with an IC50 of 0.045 μg mL
-1, in
addition to its known cytotoxic property. In order to re-
move toxicity, synthetic modification led to 5,6-dihydroni-
tidine (40), with a much weaker anti-malarial activity
(IC50 of 1.03 μg mL
-1, 23 times weaker than nitidine).
Evoxine (41), derived from Teclea gerrardii (Rutaceae)
harvested from Durban, South Africa, displayed moderate
anti-plasmodial activity against the CQS D10 strain of
P. falciparum, with IC50 value 24.5 μM [70].
Acridones
The most promising anti-plasmodial acridones derived
from the African flora include arborinine (42), xan-
thoxoline (43), normelicopicine (44), skimmianine (45),
dictamnine (46), melicopicine (47), tecleanthine (48) and
6-methoxytecleanthine (49), shown in Figure 5, isolatedfrom Teclea and Zanthoxylum species. Compound 42 was
derived from Teclea gerrardii, Zanthoxylum leprieurii and
Teclea trichocarpa (Rutaceae) and has shown anti-
plasmodial activity against 3D7 strains (IC50 = 4.5 μg mL
-1),
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-1)
[70,71]. Compounds 44 to 49 showed moderate activity
against the chloroquine-sensitive HB3 and the chloroquine-
resistant K-1 strains of P. falciparum, with respective anti-
plasmodial IC50 values of 14.7, 9.3, 59.0, 53.0, and 56.9 μM
[72]. Compound 50 (maculosidine), derived from Vepris
uguenensis (Rutaceae), exhibited anti-malarial activities at
13.8 and 40.4 μg mL-1 against the 3D7 (chloroquine sus-
ceptible, CQS) and FCM29 (chloroquine resistant, CQR)
strains of P. falciparum, respectively [73].
Amides
N-isobutyldeca-2,4-dienamide (51) and pipyahyine (52),
Figure 6, are two amides respectively derived from Hugo-
nia castaneifolia (Linaceae) and Beilschmiedia zenkeri
(Lauraceae) [74,75]. It has been shown that compound
51 had moderate anti-plasmodial activity against the K-1
strain of P. falciparum, with an IC50 value of 5.4 μg mL
-1
[74], while compound 52 showed activity against the
chloroquine-resistant W2 strain of P. falciparum, with an
IC50 value of 3.7 μM [75].
Cryptolepines
Cryptolepine (53), derived from Sida acuta (Malvaceae),
growing in Ivory Coast, has shown very good anti-
malarial activity [76]. According to Banzouzi et al., the
IC50 values obtained for the extracts from this plant
ranged from 3.9 to 5.4 μg mL-1. Purification of this active
fraction led to the identification of cryptolepine (53) as the
active anti-plasmodial constituent of the plant. Compound
53 exhibited IC50 values against the chloroquine-sensitive
strain (respectively 0.13 and 0.17 μg mL-1 after 24 and
72 hours) from Nigeria and the Fcm29 chloroquine-
resistant strain (respectively 0.17 and 0.17 μg mL-1 after 24
and 72 hours) from Cameroon. Cryptolepine derivatives
(54 to 63), Figure 7, isolated from the stems, roots and
root bark of Cryptolepis sanguinolenta (Periplocaceae)
growing in diverse regions in Africa, have also exhibited
potent anti-malarial properties [77-80].
Cimanga et al. assessed three different extracts and
four alkaloids from the root bark of Cryptolepis sangui-
nolenta in vitro against P. falciparum D-6 (chloroquine-
sensitive strain), K-1, and W-2 (chloroquine-resistant
strains). Cryptolepine (53) and its hydrochloride salt,
11-hydroxycryptolepine (56), and neocryptolepine (61)
showed strong anti-plasmodial activity against P.
falciparum chloroquine-resistant strains. Quindoline (54)
was less active. The highest activity was obtained with
cryptolepine (53). In vivo tests on infected mice showed
that cryptolepine exhibited a significant chemosuppressive
effect against Plasmodium yoelii and Plasmodium berghei,
while cryptolepine (53) had the same effect against P.
yoelii only. Compounds 54 and 56 did not show activity
in this in vivo test system [79].Another study by Paulo et al. on the roots of Cryptole-
pis sanguinolenta harvested from Guinea-Bissau led to
the isolation of cryptolepinoic acid (62) and methyl
cryptolepinoate (63) in addition to 53, 54 and 56 from
the ethanol and chlorophorm extracts of the leaves [81].
The isolated compounds and extracts were tested in vitro
against P. falciparum K1 (multidrug-resistant strain) and
T996 (chloroquine-sensitive clone). All extracts had 90%
inhibition of P. falciparum K1 growth at concentrations
<23 μg mL-1. Cryptolepine (53) was the most active alkal-
oid tested with IC50 values (0.23 μM to K1; 0.059 μM to
T996), compared to chloroquine (0.26 μM to K1;
0.019 μM to T996). The indolobenzazepine alkaloid cryp-
toheptine (57) was the second most active with IC50
values of 0.8 μM (K1) and 1.2 μM (T996). Cryptolepinoic
acid (62) showed no significant activity while its ethyl
ester derivative (63′) was active against P. falciparum K1
(IC50 = 3.7 μM). All the indoloquinoline alkaloids showed
cross-resistance with chloroquine but not the indoloben-
zazepine cryptoheptine (57). It was noticed that alkaloids
with weakly basic characteristics were active whereas other
structurally related alkaloids with different acid–base pro-
files were inactive. These observations are in agreement
with the anti-malarial mechanism of action for quinolines.
According to Hadden et al., the unusual incorporation
of the isopropyl group at the 11-position of the indolo
[3,2-b] quinoline nucleus in 11-isopropylcryptolepine
(56) is suggestive of a mixed biosynthetic origin for the
alkaloid [82].
Terpenoids
Terpenoids with most promising anti-malarial properties
are summarized in Tables 3, 4 and 5 (according to their
subclasses), while the chemical structures are shown in
Figures 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 and 19.
Clerodane and labdane diterpenoids
Mambu et al. isolated the clerodanes (13S)-ent-7β-hydroxy-
3-cleroden-15-oic acid (64), ent-7β-hydroxy- 2-oxo-3-clero-
den-15-oic acid (65), ent-2,7-dioxo-3-clero-den-15-oic acid
(66) and ent-18-(E)-caffeoyloxy-7β-hydroxy-3-cleroden-15-
oic acid (67) and the labdanes (13S)-ent-18-(E)-coumaroy-
loxy-8(17)-labden-15-oic acid (68), ent-18-(E)-caffeoyloxy-8
(17)-labden-15-oic acid (69) and ent-15-E-caffeoyloxy-8
(17)-labden-18-oic acid (70) from Nuxia sphaerocephala,
growing in Ankazobe, 100 km from Antananarivo,
Madagascar [83]. The compounds showed in vitro anti-
plasmodial activities against the FcB1 P. falciparum strain,
with respective IC50 values 14.6, 4.3, 8.0, 7.3, 11.4, 21.0,
16.0 μg mL-1. Duker-Eshun et al. obtained aframodial
(71), (E)-8(17), 12-labddiene-15,16-dial (72), (E)-15,15-
diethoxylabda-8(17),12-dien-16-al (73) and coronarin B
(74) from the fruits and leaves of Aframomum latifolium
or Aframomum sceptrum (Zingiberaceae) harvested in
Table 3 Summary of anti-malarial terpenoids derived from the African flora, part 1: clerodanes, labdanes, limonoids,
bisnorterpenes and acyclic triterpenes
Compound subclass Isolated
metabolites







64 to 70 Nuxia sphaerocephala (Loganiaceae) Leaves Ankazobe, Madagascar Mambu et al. [83]




Acrra, Ghana Duker-Eshun et al. [84]
75, 76 and 77 Turreanthus africanus (Meliaceae) Seeds Mt. Cameroon,
Cameroon





Seeds Nyasoso, Cameroon Kenmogne et al. [86]
74a, b, 82a
and 83b











Seeds Maha, Cameroon Wabo et al. [88]
Limonoids 88 Vepris uguenensis (Rutaceae) Roots Baringo District, Kenya Cheplogoi et al. [73],
Kiplimo [73]
89, 90, 91, 92,
and 93
Khaya grandifoliola (Meliaceae) Bark and
seeds
Foumban, Cameroon Bickii et al. [89]
94 and 95 Entandrophragma angolense
(Meliaceae)
Stem bark Awae forest reserve,
Cameroon
Bickii et al. [90]
96, 97, 98,
and 99
Ekebergia capensis (Zingiberaceae) Stem bark Mt Kenya, Kenya Murata et al. [91]




Roots Tanzania Thiem et al. [92]
Acyclic triterpenes 104, 105, 106,
and 107
Ekebergia capensis (Zingiberaceae) Stem bark Mt Kenya, Kenya Murata et al. [91]
108 Aframomum escapum
(Zingiberaceae)
Seeds Mogbi, Cameroon Ayimele et al. [87]
Lopez et al. [93]
a,b and ccorrespond to the respective references.
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http://www.malariajournal.com/content/12/1/449Accra, Ghana. Respective IC50 values of 25, 48, 24, and
26 μM against the chloroquine-sensistive strain (3D7)
were obtained for these compounds [84]. Anti-plasmodial
activites were also obtained for labdanes 16-oxolabda-8
(17),12(E)-dien- 15-oic acid (75), methyl-14,15-epoxy-
labda-8(17), 12(E)-diene-16-oate (76) and turraeanin A
(77), from the seeds of Turreanthus africanus (Meliaceae),
a plant generally used in preparations against fevers and
malaria in ATM [85]. Compound 75 showed the high-
est anti-plasmodial activity (IC50 of 26 μg mL
-1) on
chloroquine-sensitive P. falciparum F 32, in vitro, while
compounds 76 and 77 rather had moderate activities
[85]. Other anti-malarial labdanes of Aframomum sp.
include 3-deoxyaulacocarpin A (78), zambesiacolactones
A (79) and B (80) and aulacocarpin A (81) from seeds
of Aframomum zambesiacum [86]; coranarin B (82) from
the seeds of Aframomum escapum [87]; galanal A (83)
from the leaves of Aframomum sceptrum [84]; galanal B(84), galanolactone (85), (E)- 8β,17-epoxylabd-12-ene-5,16
dial (86) and (E) labda-8,12-diene-15,16 dial (87) from the
seeds of Aframomum arundinaceum [88]. Among these
compounds, compound 76 (3-deoxyaulacocarpin A), de-
rived from Aframomum zambesiacum, was both the least
polar and the most active compound, with an IC50 of
4.97 μM (1.73 μg/ml) [86].
Limonoids
Limonoids with good anti-plasmodial activities have
been isolated from Vepris uguenensis (Rutaceae), harvested
in Kenya [68,73], as well as from Khaya grandifoliola
(Meliaceae) and Entandrophragma angolense (Meliaceae)
harvested in Cameroon [89,90]. The chemical structures
are shown in Figure 10. Methyl uguenesonate (88) from
Vepris uguenensis displayed mild activity, with IC50 values
of 10.4 and 13.8 μg mL-1, against the CQS and CQR
strains of P. falciparum, respectively [68,73]. The bark









Cassane furanoditerpenes 109 and 110 Caesalpinia volkensii (Leguminosae) Root bark Gatamaiyo forest,
Kenya
Ochieng et al. [94]
Abietane diterpenes 111 and 112 Plectranthus hadiensis (Lamiaceae) Leaves South Africa van Zyla et al. [95]
113 Plectranthus lucidus (Lamiaceae) Leaves South Africa van Zyla et al. [95]
114 Plectranthus ecklonii (Lamiaceae) Leaves South Africa van Zyla et al. [95]
115, 116
and 117
Plectranthus purpuratus (Lamiaceae) Leaves South Africa van Zyla et al. [95]
118 Fuerstia africana (Lamiaceae) Aerial parts Ngong Hills, Kenya Koch et al. [96]
119 Hoslundia opposita (Lamiaceae) Root bark Tanzania Achenbach et al. [97]





Vernonia amygdalina (Asteraceae) Leaves Mahale National
Mountains Park,
Tanzania
Ohigashi et al. [99]
125 Vernonia brachycalyx (Asteraceae) Leaves Machakos District,
Kenya
Oketch-Rabah et al. [100]
126 Ajuga remota (Lamiaceae) Aerial parts Nairobi, Kenya Kuria et al. [101]
127, 128
and 129
Reneilmia cincinnata (Zingiberaceae) Fruits Bafut, Cameroon Tchuendem et al. [102]




Ganfon et al. [103]
132, 133,
134, and 135
Vernonia angulifolia (Asteraceae) Aerial parts University of
KwaZulu-Natal,
South Africa
Pedersen et al. [104]
136 Dicoma tomentosa (Asteraceae) Whole plant Poun, Burkina Faso Jansen et al. [105]
137 Artemisia annua (Asteraceae) Seeds Kjenzi (Bugarama), Burundi Reale et al. [106]
138 Dicoma anomala subsp. gerrardii
(Asteraceae)
Root stocks Brits region, South Africa Becker et al. [107]
139 Tithonia diversifolia (Asteraceae) Aerial parts São Tomé and
Príncipe islands
Goffin et al. [108]
140 Scleria striatinux (Cyperaceae) Roots Oku, Cameroon Efange et al. [109]
Coloratane sesquiterpenes 141 to 148 Warburgia ugandensis (Canellaceae) Stem bark Dello Menna, Ethiopia Wube et al. [110]
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a plant species widely used in the Central African
subregion to treat various ailments, including malaria have
also been investigated. Seven limonoids were isolated,
among which five were significantly active (with IC50
values ranging between 1.25 and 9.63 μg mL-1). These in-
clude: methylangolensate (89); gedunin (1.25 μg mL-1)
(90); 7-deacetylkhivorin (91); 1-deacetylkhivorin (92) and
6-acetylswietenolide (93). The same authors also investi-
gated the stem bark of Entandrophragma angolense
(Meliaceae) and isolated known limonoids with anti-
malarial activity; 7α-acetoxydihydronomilin (94), 7α-
obacunylacetate (95) and methylangolensate (89).
Compounds 89 and 95 were considerably active against
P. falciparum W2 with respective IC50 values of 2.0 and
19.5 μg mL-1.Among the four limonoids derived from the stem bark
of Ekebergia capensis, namely 7-deacetoxy-7-oxogedunin
(96), ekeberins C1 (97), C2 (98) and C3 (99), only
compound 96 exhibited significant activity against the
chloroquine-susceptible FCR-3 strain of P. falciparum,
with an IC50 of 6 μM, but it lacked efficacy against the
chloroquine-resistant K-1 strain [91].
Bisnorterpenes
Bisnorterpenes with interesting anti-plasmodial proper-
ties were purified from the roots of Salacia madagascar-
iensis (Celastraceae), a shrub found in East Africa whose
roots are used in the treatment of malaria, fever and
menorrhagia specifically in Tanzania [92]. This plant is a
rich source of bisnortriterpenes with potent antiproto-
zoal activity [45]. Four bisnortriterpenes; isoiguesterin















Talontsi et al. [111]
Pentacyclic triterpenes 154 Schefflera umbellifera (Araliaceae) Leaves South Africa Mthembu [112]
155 Maytenus senegalensis (Celastraceae) Root bark Eastern region of Sudan Khalid et al. [113]
156, 157, 158,
159, and 160
Nuxia sphaerocephala (Loganiaceae) Leaves Ankazobe, Madagascar Mambu et al. [83]
161 and 162 Hymenocardia acida (Phyllanthaceae) Bark Chad Mahmout et al. [114]
161 Cassia siamea (Fabaceae) Stems Otu (Oyo State), Nigeria Ajaiyeoba et al. [115]
163 and 164 Entandrophragma angolense
(Meliaceae)
Stem bark Awae forest reserve,
Cameroon
Bickii et al. [90]
165 Hypericum lanceolatum (Hypericaceae) Stem bark Mt. Bamboutos, Cameroon Zofou et al. [116]
166 Psorospermum glaberrimum
(Hypericaceae)
Stem bark Ekombitié, Cameroon Lenta et al. [117]
167 Baillonella toxisperma (Sapotaceae) Stem bark Korup forest reserve,
Cameroon
Mbah et al. [118]
168 Kigelia africana (Bignoniaceae) Stem bark Bandjoun, Cameroon Zofou et al. [119]
169, 170
and 171
Cogniauxia podolaena (Cucurbitaceae) Stem bark Congo Banzouzi et al. [120]
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and 6-oxoisoiguesterin (103), were reported from the
roots of this plant [92], Figure 11. However, only the first
two showed high activity, with respective IC50 values of
200 and 68 ng mL-1 against the D6 strain of P. falcip-
arum, and 170 and 68 ng mL-1 (against the W2 strain of
P. falciparum), respectively.
Acyclic triterpenes
The most active acyclic triterpenes have been found in the
stem back of Ekebergia capensis (Zingiberaceae) by
Murata et al. [91]. Four triterpenes from the stem bark of
this species, comprising two new acyclic triterpenoids,
namely ekeberin D4 (104) and D5 (105) and two
known ones (3R,22R)-2,3,22,23-tetrahydroxy-2,6,10,15,19,23-
hexamethyl-6,10,14,18-tetracosatetraene (106) and (2R,3R,
22R)-2-hydroxymethyl-2,3,22,23-tetrahydroxy- 2,6,10,15,19,
23-hexamethyl-6,10,14,18-tetracosatetraene (107) have
been identified, Figure 12. Compounds 106 and 107 ex-
hibited moderate anti-malarial activity against the FCR-3
strain of P. falciparum, with IC50 values of 55 and 18 μM
respectively, in addition to the good activities against the
chloroquine-resistant K-1 strain, against which they had
respective IC50 values of 7 and 59 μM. The triterpene 104
lacked efficacy, while 105 had an IC50 of 137 μM against
the same parasite [91]. (+) S-nerolidol (108) isolated from
the seeds of Aframomum escapum [87], is an important
constituent of essential oils used in the treatment ofmalaria. This compound is also found in Artemisia herba
alba and in lemon grass, and is able to arrest devel-
opment of the intraerythrocytic stages of the parasite.
Compound 108 was identified as the active constitu-
ent leading to 100% growth inhibition at the schizont
stage [93].Cassane furanoditerpenes
Ochieng et al. isolated the cassane furanoditerpenes;
deoxycaesaldekarin C (109) and caesaldekarin C (110)
from the the chloroform and ethyl acetate extracts of the
root bark of Caesalpinia volkensii from Kenya (Figure 13).
These two compounds have exhibited antinociceptive and
anti-plasmodial activities [94]. The anti-plasmodial activ-
ities were evaluated against chloroquine-sensitive (D6)
and chloroquine-resistant (W2), with respective IC50
values of 25.67 and 30.33 μg mL-1 for compound 109 and
respective IC50 values of 34.44 and 30.69 μg mL
-1 for
compound 110. The results however demonstrated that
Caesalpinia volkensii and other members of this genus
contain cassane furanoditerpenes, which play a role in
the medicinal properties of their plant root barks. The
antinociceptive action in chemical models of nocicep-
tion in mice suggests that the root bark extract and the
active principles (furanoditerpenes) represent potential
therapeutic options for the management of pain related
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Aframodial (71) (E)-8(17), 12-labddiene-15,16-dial (72)
β
β
Figure 8 Clerodane and labdane diterpenoids from African medicinal plants with anti-malarial activity - I.
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The anti-malarial properties of Plectranthus sp. (Lamiaceae),
harvested in South Africa, have been determined by van
Zyla et al. [95]. Seven abietane diterpenes (see Figure 14)
were isolated from Plectranthus hadiensis, Plectranthus
lucidus, Plectranthus ecklonii, Plectranthus purpuratus
subsp. purpuratus and Plectranthus purpuratus subsp.
tongaensis; 7α-formyloxy-6,12-dihydroxy-abieta- 8,12-diene-
11,14-dione (111), 7α-acetoxy-6,12-dihydroxy-abieta-8,
12- diene-11,14-dione (112), 11-hydroxy-2α-(4-hydroxy-
benzoyloxy)- abieta-5,7,9(11),13-tetraene-12-one (113),
11-hydroxy-2α-(3,4-dihydroxybenzoyloxy) abieta-5,7,9
(11),13-tetraene-12-one (114), 11-hydroxy-19-(methyl-buten-2-oyloxy)-abieta −5,7,9 (11),13-tetraene-12-one (115), 11-
hydroxy-19-(4-hydroxy-benzoyloxy)-abieta-5,7,9(11),
13-tetraene-12-one (116) and 11-hydroxy-19-(3,4-dihy-
droxybenzoyloxy)-abieta-5,7,9(11),13-tetraene-12-one
(117). These compounds were tested for their anti-
plasmodial activity and for their ability to inhibit β-
haematin formation. Overall, they showed good activity
(IC50 values ranging from 3.11 to 14.65 μM), with com-
pound 114 being 62% as effective as chloroquine in inhibit-
ing β-haematin formation. Compounds 111, 114 and 117
were more active than quinine. However, the cytotoxicity
profile indicated a low degree of specificity towards the
malaria parasite. When combined with quinine, three
RCHO
16-Oxolabda-8(17),12(E)-dien-
15-oic acid (75): R = CO2H
CHO
methyl-14,15-epoxylabda-8(17),




R1 = H, R2 = H
Aulacocarpin A (81):






Zambesiacolactone A (79): R1 = OH, R2 = H, R3 = OH












Galanal A (83): R = OH



















Figure 9 Clerodane and labdane diterpenoids from African
medicinal plants with anti-malarial activity – II.
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tive manner whereas compound 111 interacted syner-
gistically [95].
Two other abietane diterpenes with anti-plasmodial
activities; ferruginol (118) and 3-O-benzoylhosloppone
(119), were respectively isolated by Koch et al. [96] and
Achenbach et al. [97]. Compound 118 was isolated from
the methanol extract of dried aerial parts (leaves and
stems) of Fuerstia africana (Lamiaceae), a low-growing
herb endemic to tropical East Africa [96], while com-
pound 119 was isolated from the root bark of Hoslundia
opposita (Lamiaceae), harvested in Tanzania [97]. The
anti-malarial activity of compound 118, determined
using the D6 (chloroquine-sensitive derived from CDC
Sierra Leone) clone of P. falciparum, showed a strong
activity with an IC50 of 1.95 μg mL
-1 compared to
chloroquine IC50 = 1.94 μg mL
-1 [96]. Meanwhile, 3-O-
benzoylhosloppone (119) inhibited the growth of the
multidrug resistant strain K1 of P. falciparum in vitro
with an IC50 value of 0.4 μg mL
-1 [97]. A bioactivity-
guided fractionation of the petroleum ether extract of
the leaves of Hyptis suaveolens, from Nigeria, led to the
isolation of the abietane-type diterpenoid endoperoxide,
13α-epi-dioxiabiet-8(14)-en-18-ol (120), a molecule with
high anti-plasmodial activity (IC50 = 0.1 μg mL
-1) [98].
Sesquiterpenes and sequiterpene lactones
Sequiterpenes derived from Vernonia sp. are known to
have interesting anti-plasmodial activities. The com-
pounds include vernodalin (121), vernodalol (122), ver-
nolide (123), hydroxyvernolide (124), derived from the
leaves of Vernonia amygdalina by Ohigashi et al. [99], in
addition to 16,17- dihydrobrachycalyxolide (125) iso-
lated from the leaves of the sister species, Vernonia
brachycalyx, as a major anti-plasmodial compound, by
Oketch-Rabah et al., Figures 15 and 16 [100]. These
compounds exhibited moderate anti-plasmodial activity
against the multidrug-resistant K-1 strain of P. falcip-
arum, vernodalin (121) being the most active compound
with an IC50 value of 4 μg mL
-1. Meanwhile, compounds
122, 123 and 124 had IC50 values of 4.2, 8.4 and
11.4 μg mL-1, respectively [99]. The measured activities
of the compounds correlates with the uses of the plants
in ATM (the leaves of Vernonia amygdalina are used in
the treatment of various diseases, including malaria).
Quantitative analysis showed that young leaves of this
species have a higher concentration of compound 121
than the other derived compounds, suggesting that the
anti-malarial efficacy of the leaf extracts of this species
may be partly due to the high content of this NP. It has
also been reported that dry leaves of Vernonia brachycalyx
contain 0.2-0.4% of the sesquiterpene dilactone 125. This
compound exhibited moderate to high anti-plasmodial ac-
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Figure 10 Limonoids from African medicinal plants with antiplasmodial activity.
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http://www.malariajournal.com/content/12/1/449strains, with IC50 values of 4.2, 13.7, 3.0, and 16 μg mL
-1,
respectively [100]. In spite of the anti-plasmodial activity
of this compound, it also had higher toxicity against hu-
man lymphocytes, indicating that the anti-plasmodial ac-
tivity may have been due to the general toxicity the
compound had on cells. Despite these observations, the
leaves of this species are still used in the treatment of mal-
aria and parasitic infections in East Africa [45]. Ajugarin-1
(126) is another sesquiterpene, which has been reported
from aerial parts of Ajuga remota, harvested in Kenya
[101]. The compound has exhibited moderate anti-
malarial properties against the chloroquine-sensitive
FCA20/GHA strain of P. falciparum, with an IC50 of
23 μM [101].
The sesquiterpenoids oplodiol (127), 5E,10(14)-germa-
cradien-1β,4β-diol (128) and 1(10) E,5E-germacradien-
4α-ol (129), derived from Reneilmia cincinnata, with
respective IC50 values of 4.17, 1.63 and 1.54 μM, wereused to validate the use of this plant in ATM to cure
malaria and other fevers in Cameroon [102]. In addition,
Ganfon et al. investigated the antiparasitic activities of
two sesquiterpenic lactones isolated from Acanthosper-
mum hispidum harvested in Benin Republic [103]. From
their results, two known sesquiterpenic lactones were
isolated: 15-acetoxy-8β-[(2-methylbutyryloxy)]-14-oxo-4,
5-cis-acanthospermolide), 130 and 9α-acetoxy-15-hydroxy-
8β-(2-methylbutyryloxy)-14-oxo- 4,5-trans-acanthosper-
molide), 131. Compounds 130 and 131 showed in vitro
anti-plasmodial activity against the chloroquine-sensitive
strain (3D7) with IC50 values of 2.9 and 2.23 μM, respect-
ively. Only 131 showed a high selectivity index (SI: 18.4)
on Plasmodium compared to cytotoxicity against human
fibroblasts cell line (WI38). Furthermore, the crude acidic
water extract and fractions containing one of the two iso-
lated compounds displayed a weak in vivo anti-malarial


































Figure 12 Anti-malarial acyclic triterpenes from African medicinal pla
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http://www.malariajournal.com/content/12/1/449causing a delayed effect. In vivo acute (2000 mg kg-1) and
sub-acute (1000 mg kg-1) toxicity tests of the crude acidic
water extract did not show toxicity. Moreover, the crude
acidic water extract, fractions and pure isolated com-
pounds from Acanthospermum hispidum showed promis-
ing in vitro anti-plasmodial activity. Despite the fact that
this study did not show in vivo acute and subacute toxic-
ities of the crude acidic water extract, its weak in vivo
anti-malarial activity and the in vitro cytotoxicity of pure
compounds and enriched extracts containing 130 and
131 indicate that the aerial parts of this plant should be
used with caution for malaria treatments [103].
The combined use of bioassay-guided fractionation
based on in vitro anti-plasmodial assay and dereplication
based on HPLC–PDA–MS–SPE–NMR by Pederson et al.
[104], led to isolation of (6S,7R,8S)-14-acetoxy-8-[2-
hydroxymethylacrylat]-15-helianga-1(10),4,11(13)-trien-15-
al-6,12-olid or vernangulide A (132) and (5R,6R,7R,8S,
10S)-14-acetoxy-8-[2-hydroxymethylacrylat]-elema-1,3,11
(13)-trien-15-al-6,12-olid or vernangulide B (133), along
with vernodalol (134), vernodalin (135) and 11,13β-
dihydroxyvernodalin (136) from the dichloromethane/




















Figure 13 Promising anti-malarial cassane furanoditerpenes
from African medicinal plants.
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http://www.malariajournal.com/content/12/1/449of Distephanus angulifolius. The isolated compounds
showed IC50 values in the range 1.6 to 3.8 μM and 2.1 to
4.9 μM against chloroquine-sensitive D10 and chloroquine-
resistant W2 P. falciparum strains, respectively. Janson et al.
identified urospermal A-15-O-acetate (136) as the main
active compound responsible for the anti-plasmodial ac-
tivity of Dicoma tomentosa (Asteraceae) from Burkina





































Figure 14 Promising anti-malarial abietane diterpenes from African mcompound was <1 μg mL-1 against both 3D7 and W2
strains. Compound 136 was found to be the main cytotoxic
compound (SI = 3.3). A rapid quantification of the anti-
malarial drug, artemisinin (137) in Artemisia annua plants
cultivated for the first time in Burundi by Reale et al., re-
vealed the prospect of cultivating Artemisia and eventually
using the active principle to offer the population of
Burundi a fundamental resource in a country where mal-
aria is endemic [106].
Standard phytochemical analysis techniques, including
solvent-solvent extraction, thin-layer- and column chro-
matography, were used by Becker et al. to isolate a
eudesmanolide-type sesquiterpene lactone, dehydrobra-
chylaenolide (138), as the main active constituent of
Dicoma anomala subsp. gerrardii from the Brits region
of North West Province of South Africa [107]. The com-
pound demonstrated an in vitro IC50 of 1.865 μM against
a chloroquine-sensitive strain (D10) of P. falciparum. The
biological activities of synthetic analogues of compound
138 showed that a methylene lactone group must be
present in the eudesmanolide before any significant anti-


















































































Figure 15 Some anti-malarial sesquiterpenes and sesquiterpene
lactones from African medicinal plants - I.
Amoa Onguéné et al. Malaria Journal 2013, 12:449 Page 18 of 25
http://www.malariajournal.com/content/12/1/449in the artemisinins and suggests that eudesmanolide-type
sesquiterpene lactones have a different mode of action
from artemisinins. This hypothesis was further confirmed
by microarray gene ontology analysis [107]. The ether
extract from aerial parts of Tithonia diversifolia collected
in São Tomé and Príncipe demonstrated good anti-
plasmodial activity (IC50 of 0.75 μg mL
-1 against the FCA
strain) and fractionation of this extract yielded the sesqui-
terpene lactone tagitinin C (139) as an active compound
against P. falciparum (IC50 of 0.33 μg mL
-1 against the
FCA strain) [108].Okundoperoxide (140), a new compound with a cyclic
endoperoxide moiety, was isolated by Efange et al. from
Scleria striatinux (Cyperaceae), a spice commonly used
in Cameroonian folk medicine to treat malaria and
other fevers. This molecule exhibited significant anti-
plasmodial activity, with IC50 values of 0.47, 0.48, 1.49,
and 1.30 μg mL-1, on P. falciparum W2, D6, K1, and
NF54, respectively. Moreover, the molecule showed no
significant toxicity against mammalian cells [109].
Coloratane sesquiterpenes
Wube et al. demonstrated the antiprotozoal activity of
Warburgia ugandensis (Canellaceae) from Ethiopia to-
wards Trypanosoma brucei rhodesiense and P. falciparum
in vitro and attributed the anti-plasmodial activity to
the presence of drimane and coloratane sesquiterpenes.
These include 4(13),7-coloratadiene-12,11-olide (141),
11α-hydroxymuzigadiolide (142), muzigadial (143), 6α,
9α-dihydroxy-4(13),7-coloratadiene-11,12-dial (144), cin-
namolide (145), cinnamolide-3β-acetate (146), mukaadial
(147) and ugandensidial (148), Figure 17. The anti-
plasmodial assays also revealed that the six coloratane and
six drimane sesquiterpenes isolated from this extract ex-
hibited significant antitrypanosomal activity with IC50
values ranging from 0.45 to >114 μM. Among the com-
pounds tested against the malaria parasite P. falciparum
11α-hydroxymuzigadiolide (142) was most active with
an IC50 value of 6.40 μM [110].
Beilshmiedic acid derivatives
Beilschmiedic acid derivatives exhibiting antibacterial
and anti-plasmodial activities were obtained from Beilschmie-
dia cryptocaryoides (Lauraceae) collected from Madagascar
(Table 5). The work of Talontsi et al. [111] led to the isola-
tion of four new beilschmiedic acid derivatives, cryptobeilic
acids A−D (149 to 152), and tsangibeilin B (153), Figure 19.
Compounds 149 to 153 exhibited anti-plasmodial activity
against erythrocytic stages of chloroquine-resistant P.
falciparum strain NF54 (with IC50 values ranging from
5.35 to 17.70 μM) and weak cytotoxicity against L6 cell
lines (with IC50 values ranging from 20.4 to 61.0 μM), the
most promising antiplasmodial activity being shown by
compound 150.
Pentacyclic triterpenes
The crude organic (methanol/dichloromethane (1:1)) ex-
tract of the leaves of Schefflera umbellifera (Araliaceae)
exhibits promising anti-malarial activity. Bioassay-guided
fractionation of this extract yielded the active compound,
3-hydroxy-20(29)-lupen-28-ol (154), Figure 19, which ex-
hibited good anti-plasmodial activity (IC50 of 3.2 μg mL
-1),
when tested against a chloroquine-susceptible malarial
strain (D10). The reference compound (chloroquine) gave
an IC50 of 27.2 ng mL

































































































































Figure 17 Coloratane sesquiterpenes from African medicinal plants with anti-malarial activity.











Cryptobeilic acid B (150)









Figure 18 Beilshmiedic acid derivatives from African medicinal
plants with anti-malarial activity.
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friedela-1(10),3,5,7-tetraen-carboxylic acid-(29)-methylester
(155) was obtained by a bioactivity directed fractionation
of the chloroform extract of the root bark of Maytenus
senegalensis (Celasterceae) harvested from Sudan by Kha-
lid et al. [113]. The in vitro anti-plasmodial activity of the
isolated compound against chloroquine-resistant strain
(Dd2) of P. falciparum was IC50 = 0.5 μg mL
-1, while the
cytotoxicity on lymphocyte proliferation model was de-
tected at IC50 = 6.8 μg mL
-1. The lupane-type triterpenoids
3-oxolupenal (3-oxolup-20(29)-en-30-al) (156), 3β-
hydroxylupenal (3β-hydroxylup-20(29)-en-30-al)
(157) and 3-oxolupenol (30-hydroxylup-20(29)-
en-3-one) (158) were obtained from the leaves of Nuxia
sphaerocephala (Loganiaceae), along with oleanolic acid
(160), its acetylated ester (159), lupeol, uvaol, ursolic acid,
and 3β-acetylursolic acid [83]. Among the compounds iso-
lated from this study, 156 and 157 showed the best inhibi-
tory activity against P. falciparum with the IC50 values
between 1.55 and 4.67 μg mL-1 in vitro, respectively.
Another lupane-type triterpene, lupeyl docosanoate
(162), was isolated from the bark extract of Hymenocar-
dia acida (Phyllanthaceae) collected in Chad, along with
lupeol (161) and β-sitosterol by Mahmout et al. [114].
The anti-malarial property of compound 162 justifies
the ethnobotanic use of the plant in the treatment of
malaria. Cassia siamea (Fabaceae) was identified from
an ethnobotanical survey of southwest Nigeria as a rem-
edy for febrile illness. Bioassay-guided fractionation of
stem bark of the plant extract, using the parasite lactate
dehydrogenase assay and multi-resistant strain of P.
falciparum (K1) for assessing the in vitro anti-malarial
activity led to the isolation of emodin and lupeol (161)
from the ethyl acetate extract [115]. Both compounds
were found to be the active principles responsible for
the anti-plasmodial property with IC50 values of 5 μg mL
1,
for each compound. The compounds 22-hydroxyhopan-
3-one (163) and 24-methylene cycloartenol (164) from
the stem bark of Entandrophragma angolense (Melia-
ceae) had moderate activities against P. falciparum W2
[90]. Zofou et al. evaluated the anti-plasmodial activity
of betulinic acid (165) from the stem bark of the African
St John’s wort, Hypericum lanceolatum (Hypericaceae).
The compound had an IC50 of 2.05 μg mL
-1 [116]. The
n-hexane extract of Psorospermum glaberrimum from
Cameroon showed good anti-plasmodial activity against
the P. falciparum W2 strain, with IC50 of 0.87 μg mL
-1
[117]. Lenta et al. isolated betulinic acid (165) and
friedelan-3-ol (166) from this extract. The measured
in vitro activity of compound 165 against the P. falcip-
arum W2 strain gave an IC50 of 2.33 μg mL
-1. Mbah
et al. isolated 3-O-betulinic acid p-coumarate (167) from
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Figure 19 Pentacyclic triterpenes from African medicinal plants with antiplasmodial activity.
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the stem bark of Kigelia africana (Bignoniaceae). This
compound exhibited an IC50 of 0.90 μg mL
-1 against the
W2 strain of P. falciparum.
Cogniauxia podolaena (Cucurbitaceae) is traditionally
used in Congo Brazzaville for the treatment of malaria.
The anti-plasmodial activity of the plant and some of
the isolated compounds responsible for its activity were
assessed by Banzouzi et al. [120]. Cucurbitacin B (169),
cucurbitacin D (170) and 20-epibryonolic acid (171)
were assayed for anti-plasmodial activity (on FcM29, a
chloroquine-resistant strain of P. falciparum) and cyto-
toxicity (on KB and Vero cell lines). The compounds
showed respective IC50 values of 1.6, 4.0 and 2.0 μg mL
-1
on FcM29. Compounds 169 and 170 both showed
high cytotoxicity whereas 171 showed a better select-
ivity index.
Conclusions
In this review an attempt has been made to document
anti-malarial activities of NPs derived from African me-
dicinal plants. It covers results published until the time
of submission of the article. The first part of the review
involves naturally occurring, anti-plasmodial/anti-malar-
ial alkaloids and terpenoids while the second part of the
review focuses on the remaining classes of compounds.
Some of the compounds have been isolated from plants
reputed to have a long history of usage in ATM, infer-
ring that knowledge from ATM could be very useful in
drug discovery efforts from African medicinal plants.
From every indication, recent research efforts on new
anti-malarial agents should focus on two main areas: the
search for new chemical entities (NCEs) of natural/semi-
synthetic origin, and the development of phytomedicines
[37]. It should be mentioned that African researchers
have, knowingly or unknowingly, blown the former av-
enue out of proportion. This is basically as a result of
the fact that most of the research activities on medicinal
plants going on in Africa are carried out by academic re-
search groups and the focus is on publications, not appli-
cation. This calls for the need to develop the necessary
applications required to turn acquired knowledge on NPs
derived from African medicinal plants into concrete appli-
cations in phytomedicine, within an industrial setting. It
has been noticed that among the anti-malarials mentioned
in this review, most have never been tested for cytotoxicity
and very few have been tested for in vivo antoplasmodial
activity. Another limitation is the, often small, quantities
of compounds isolated from the plants which frustrate
ambitions of large-scale screening efforts. Since some
complex anti-malarial mixtures derived from plant ex-
tracts sometimes loose their anti-malarial properties when
pure compounds are isolated, due to synergism of mole-
cules in mixture, the trend towards the development oftotal extracts into phytomedicines or improved trad-
itional preparations is to be encouraged. Moreover, the
isolation and characterization of NPs is an expensive en-
deavour, not within the reach of the average African re-
search group. However, the attempt to validate ATM
remedies as drugs will also face a number of limitations,
among which are dosage determinations, variations of the
concentration of the active ingredients in the plants with
seasonal variations, the rapid loss of tropical forests and
the extinction of key species, intellectual property rights
management, the intervariability of plant species, quality
control, and the conservation of biodiversity. The recon-
ciliation between academic-oriented research and the de-
velopment of phytomedicines could be feasible with the
establishment of African centres of excellence in drug dis-
covery [121], an initiative of the African Network for
Drugs and Diagnostics Innovation (ANDI) [122], ATM
being a major hub in this endeavour. In order to enhance
modern drug discovery efforts from phytochemicals de-
rived from the African flora, a recent effort by the authors
of this paper has been to develop virtual libraries including
NPs derived from African medicinal plants that have been
reported in the literature, for computer-aided drug discov-
ery (CADD). These include the CamMedNP database,
containing three-dimensional structures of NPs derived
from Cameroonian medicinal plants [123], the ConMedNP
database, which covers ten countries in the Central African
geographical region, converging the Congo Basin [124]
and the AfroDb database, which is a select highly potent
dataset, covering compounds with remarkable activities
derived from plants across the entire continent [125].
Such databases could serve as starting points for virtual
screening (VS) and CADD, leading to the identification
of in silico hits, followed by validation by biological as-
says. These efforts have been in line with the prediction
of DMPK profiles of the NPs, with a view to prioritizing
hit selection during VS campaigns [125-127].Abbreviations
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